Memantine as a neuroprotective agent in early phases of psychosis

被引：2

作者：

Fusar-Poli, Paolo ^{[1
]}

Pellegrini, Francesco ^{[1
]}

Cortesi, Mariachiara ^{[1
]}

机构：

[1] Univ Pavia, Dept Psychobehav Hlth Sci, I-27100 Pavia, Italy

来源：

MEDICAL HYPOTHESES | 2007年 / 68卷 / 02期

关键词：

D O I：

10.1016/j.mehy.2006.07.026

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：459 / 460

页数：2

共 7 条

[1]

Costa E., 2004, Critical Reviews in Neurobiology, V16, P1, DOI 10.1615/CritRevNeurobiol.v16.i12.10

[2] Glutamate and schizophrenia: beyond the dopamine hypothesis. [J].

Joseph T. Coyle .

Cellular and Molecular Neurobiology, 2006, 26 (4) :365-384

[3] Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond [J].

Lipton, SA .

NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (02) :160-170

[4] Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia [J].

Moghaddam, B .

PSYCHOPHARMACOLOGY, 2004, 174 (01) :39-44

[5] Neuropsychological functioning in first-episode psychosis - evidence of specific deficits [J].

Riley, EM ;

McGovern, D ;

Mockler, D ;

Doku, VCK ;

OCeallaigh, S ;

Fannon, DG ;

Tennakoon, L ;

Santamaria, M ;

Soni, W ;

Morris, RG ;

Sharma, T .

SCHIZOPHRENIA RESEARCH, 2000, 43 (01) :47-55

[6] Pharmacological intervention in the initial prodromal phase of psychosis [J].

Ruhrmann, S ;

Schultze-Lutter, F ;

Maier, W ;

Klosterkötter, J .

EUROPEAN PSYCHIATRY, 2005, 20 (01) :1-6

[7]

TUOMINEN HJ, COCHRANE DATABASE SY

← 1 →